Brenner Tumor of Ovary - 25 Studies Found Recruiting : Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer : Clear Cell Adenocarcinoma Fallopian Tube Clear Cell Adenocarcinoma Biological: Bevacizumab Given Active, not recruiting : Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer : Fallopian Tube Carcinosarcoma Fallopian Tube Clear Cell Adenocarcinoma Biological: Bevacizumab Given Completed : Collecting Tumor Samples From Patients With Gynecological Tumors : Borderline Ovarian Clear Cell Tumor Borderline Ovarian Serous Tumor Chemotherapeutic Agent Toxicity Endometrial Adenocarcinoma : 2008-12-20 : Drug: Paclitaxel Given IV or i Completed : Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer : Fallopian Tube Clear Cell Adenocarcinoma Fallopian Tube Endometrioid Adenocarcinoma : 2005-12-06 : Biological: Bevacizumab Given <<< Previous